Results 131 to 140 of about 5,988 (201)

Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: network meta-analysis

Frontiers in Pharmacology
ObjectivesEvidences for anticoagulation strategies in cirrhotic with portal vein thrombosis (PVT) are still insufficient. This study aims to comprehensively compare the therapeutic effects of different therapeutic therapeutic measures in individuals ...
Hui-Jun Li, Fu-Qiang Yin, Yu-Tong Ma, Teng-Yu Gao, Yu-Ting Tao, Xin Liu, Xian-Feng Shen, Chao Zhang   +7 more
doaj   +1 more source

Insights into the modulation of age‐related macular degeneration: Molecular and systems‐level perspectives

Acta Ophthalmologica, Volume 104, Issue S293, Page S4-S35, October 2026.
ENGLISH SUMMARY In developed countries, age‐related macular degeneration (AMD) is the leading cause of visual impairment in the aging population. Understanding of its pathogenesis is limited and the number of patients is predicted to continue rising. AMD is classified into two main forms: dry and neovascular AMD (dAMD and nAMD, respectively).
Hanna Heloterä
wiley   +1 more source

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli, Arianna Gatti, Flora Ierna, Elena Riccardi, Irene Cuppari   +4 more
wiley   +1 more source

How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor Analysis

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 951-960, October 2026.
ABSTRACT Borderline prolongation of routine clotting assays—particularly the activated partial thromboplastin time (aPTT)—is a common interpretative challenge in laboratory hematology. These reproducible but mildly prolonged results often lie just beyond the upper reference limit and can trigger unnecessary follow‐up, delays, or misinterpretation ...
Nikolaos Androulakis, Eleni Nioti, Antonios Dilintas, Christina Kalpadakis   +3 more
wiley   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part III) on Rate and Rhythm Control in Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Minglong Chen, Kyoko Soejima, Melanie Gunawardene, Pipin Kojodjojo, Hailei Liu, Tong Liu, Shinsuke Miyazaki, Itsuro Morishima, Prashanthan Sanders, Hung Fat Tse, Takanori Yamaguchi, Eue‐Keun Choi, Boyoung Joung, Rungroj Krittayaphong, Melissa Middeldorp, Gregory Y. H. Lip, Hui‐Nam Pak, Tze‐Fan Chao, Young‐Hoon Kim, Shih‐Ann Chen   +19 more
wiley   +1 more source

Concurrent use of DOACs and pharmacodynamic interacting drugs is associated with an increased risk of major bleeding compared with patients using DOACs alone: Nested case-control study in UK CPRD [PDF]

, 2018
Background: Although many studies on bleeding risk associated with use of direct oral anticoagulants (DOACs) are conducted, the effect of concurrent use of potentially interacting drugs on this risk is not well studied.
Van Den Ham, Hendrika A., Souverein, Patrick C., Zhang, Yumao, Maitland-Van Der Zee, A.H., De Boer, Anthonius, Gardarsdottir, Helga, PECP - Centre for Pharmaceutical Policy and Regulation, PECP - Centre for Pharmacoepidemiology, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology   +9 more
core  

Role of direct oral anticoagulants in gastrointestinal cancerassociated thrombosis "gpractical issues in clinical practice"—narrative review

Objective: Direct oral anticoagulants (DOAC) are now considered an effective treatment option for cancer associated thrombosis (CAT). There are still controversies in the use of DOACs in CAT associated with gastrointestinal (GI) malignancies. Background:
Mahmood, Shahid, Yip, Desmond, Manoharan, Sathya, Jain, Ankit, Amira , Mohammad   +4 more
core   +1 more source

Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry

, 2020
The optimal antithrombotic therapy for patients undergoing TAVI with concomitant indication for oral anticoagulation remains unclear. In this high-risk population group, there is a paucity of data with regards to the use of DOACs. In the present study we
Malik, I.S., Dalby, M., Watson, S., Vavuranakis, M., Ruparelia, N., Panoulas, V., Jabbour, R.J., Kabir, T., Nakamura, S., Mikhail, G., Kalogeras, K., Naganuma, T.   +11 more
core  

Using direct anticoagulants (DOACs) in cancer and other high-risk populations [PDF]

, 2016
The major practical advantage of the direct oral anticoagulants (DOACs), comprising the thrombin inhibitor dabigatran and the factor Xa inhibitors apixaban, edoxaban, and rivaroxaban, over vitamin K antagonists is their fixed dosing without the need ...
Florina Topliceanu, Mihai Șotcan, Cristina Vârlan, Lavinia Bârsan, Eduard Dănăilă   +4 more
core  

DOAC drug interactions management resource

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2022
Ayush Chadha, Micheal Guirguis, Tammy J. Bungard   +2 more
openaire   +2 more sources